The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Metabolic Genetic Testing Market Research Report 2025
Synopsis
Metabolic genetic testing refers to a type of genetic testing that focuses on identifying genetic variations or mutations that can impact a person’s metabolism. These tests aim to diagnose and understand inherited metabolic disorders, which are conditions caused by genetic defects that affect the body’s normal metabolic processes.
The global Metabolic Genetic Testing market was valued at US$ 1080 million in 2023 and is anticipated to reach US$ 1706.6 million by 2030, witnessing a CAGR of 6.8% during the forecast period 2024-2030.
The global metabolic genetic testing market refers to the market for genetic testing services and products specifically focused on identifying and diagnosing metabolic disorders. This market includes various testing methods, technologies, and services related to the detection of genetic variations associated with inherited metabolic conditions.
Here are some key insights into the global metabolic genetic testing market:
Market Size and Growth: The global metabolic genetic testing market has witnessed significant growth in recent years and is projected to continue expanding. Factors driving market growth include increasing awareness and understanding of metabolic disorders, advancements in genetic testing technologies, rising prevalence of genetic metabolic disorders, and growing demand for personalized medicines.
Testing Methods: Metabolic genetic testing can be conducted using various methods, including DNA sequencing, targeted gene panels, chromosomal microarray analysis (CMA), and whole exome or genome sequencing. These methods enable the detection of specific genetic variations and mutations associated with metabolic disorders.
Application Areas: Metabolic genetic testing finds applications in various clinical areas, including prenatal testing, newborn screening, carrier testing, diagnostic testing, and research applications. Prenatal testing helps detect genetic metabolic disorders in fetuses, while newborn screening programs aim to identify metabolic disorders in newborns to enable early intervention and treatment. Diagnostic testing is performed for individuals with symptoms or suspected metabolic disorders, while carrier testing helps identify individuals carrying a genetic mutation associated with a metabolic disorder.
Market Players: The global metabolic genetic testing market is highly competitive, with several established players and emerging companies. Some of the key players in the market include PerkinElmer Inc., Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics, Centogene AG, Blueprint Genetics, and Eurofins Scientific, among others. These companies offer a range of genetic testing products and services for metabolic disorders and are investing in research and development to enhance their testing offerings and expand their market presence.
Geographic Analysis: North America currently holds a significant share of the global metabolic genetic testing market, attributed to factors such as well-established healthcare infrastructure, advanced genetic testing technologies, increasing awareness, and high healthcare expenditure. Europe and the Asia-Pacific region are also witnessing substantial growth, driven by expanding healthcare infrastructure, rising prevalence of metabolic disorders, and increasing adoption of genetic testing in these regions.
Regulatory Landscape: Regulatory bodies, such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), provide guidelines and regulations for the approval and use of genetic testing services. Compliance with regulatory standards and obtaining necessary approvals or clearances is crucial for market entry and commercialization of metabolic genetic testing products and services.
Collaborations and Partnerships: Companies operating in the metabolic genetic testing market often engage in collaborations, partnerships, and strategic alliances to expand their genetic testing portfolio, enhance their geographic presence, and leverage complementary expertise. These collaborations aim to accelerate innovation, broaden test offerings, and improve access to metabolic genetic testing services.
The global metabolic genetic testing market is experiencing significant growth driven by factors such as increasing prevalence of metabolic disorders, advancements in genetic testing technologies, and growing demand for personalized medicine. Market players are constantly investing in research and development to enhance their testing capabilities, expand their product offerings, and cater to the evolving needs of healthcare providers and patients. As awareness and demand for metabolic genetic testing continue to rise, the market is expected to witness further expansion in the coming years.
This report aims to provide a comprehensive presentation of the global market for Metabolic Genetic Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Metabolic Genetic Testing.
Report Scope
The Metabolic Genetic Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Metabolic Genetic Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Metabolic Genetic Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Centogene N.V
MedGenome
Blueprint Genetics Oy
Invitae Corporation
Quest Diagnostics
Orig3n
Bionano Genomics
Devyser
PerkinElmer Genomics
LabCorp
Centogene
PreventionGenetics
Segment by Type
DNA Sequencing
Targeted Gene Panels
Chromosomal Microarray Analysis (CMA)
Segment by Application
Hospitals
Specialty Clinics
Diagnostics Laboratories
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Metabolic Genetic Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Metabolic genetic testing refers to a type of genetic testing that focuses on identifying genetic variations or mutations that can impact a person’s metabolism. These tests aim to diagnose and understand inherited metabolic disorders, which are conditions caused by genetic defects that affect the body’s normal metabolic processes.
The global Metabolic Genetic Testing market was valued at US$ 1080 million in 2023 and is anticipated to reach US$ 1706.6 million by 2030, witnessing a CAGR of 6.8% during the forecast period 2024-2030.
The global metabolic genetic testing market refers to the market for genetic testing services and products specifically focused on identifying and diagnosing metabolic disorders. This market includes various testing methods, technologies, and services related to the detection of genetic variations associated with inherited metabolic conditions.
Here are some key insights into the global metabolic genetic testing market:
Market Size and Growth: The global metabolic genetic testing market has witnessed significant growth in recent years and is projected to continue expanding. Factors driving market growth include increasing awareness and understanding of metabolic disorders, advancements in genetic testing technologies, rising prevalence of genetic metabolic disorders, and growing demand for personalized medicines.
Testing Methods: Metabolic genetic testing can be conducted using various methods, including DNA sequencing, targeted gene panels, chromosomal microarray analysis (CMA), and whole exome or genome sequencing. These methods enable the detection of specific genetic variations and mutations associated with metabolic disorders.
Application Areas: Metabolic genetic testing finds applications in various clinical areas, including prenatal testing, newborn screening, carrier testing, diagnostic testing, and research applications. Prenatal testing helps detect genetic metabolic disorders in fetuses, while newborn screening programs aim to identify metabolic disorders in newborns to enable early intervention and treatment. Diagnostic testing is performed for individuals with symptoms or suspected metabolic disorders, while carrier testing helps identify individuals carrying a genetic mutation associated with a metabolic disorder.
Market Players: The global metabolic genetic testing market is highly competitive, with several established players and emerging companies. Some of the key players in the market include PerkinElmer Inc., Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics, Centogene AG, Blueprint Genetics, and Eurofins Scientific, among others. These companies offer a range of genetic testing products and services for metabolic disorders and are investing in research and development to enhance their testing offerings and expand their market presence.
Geographic Analysis: North America currently holds a significant share of the global metabolic genetic testing market, attributed to factors such as well-established healthcare infrastructure, advanced genetic testing technologies, increasing awareness, and high healthcare expenditure. Europe and the Asia-Pacific region are also witnessing substantial growth, driven by expanding healthcare infrastructure, rising prevalence of metabolic disorders, and increasing adoption of genetic testing in these regions.
Regulatory Landscape: Regulatory bodies, such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), provide guidelines and regulations for the approval and use of genetic testing services. Compliance with regulatory standards and obtaining necessary approvals or clearances is crucial for market entry and commercialization of metabolic genetic testing products and services.
Collaborations and Partnerships: Companies operating in the metabolic genetic testing market often engage in collaborations, partnerships, and strategic alliances to expand their genetic testing portfolio, enhance their geographic presence, and leverage complementary expertise. These collaborations aim to accelerate innovation, broaden test offerings, and improve access to metabolic genetic testing services.
The global metabolic genetic testing market is experiencing significant growth driven by factors such as increasing prevalence of metabolic disorders, advancements in genetic testing technologies, and growing demand for personalized medicine. Market players are constantly investing in research and development to enhance their testing capabilities, expand their product offerings, and cater to the evolving needs of healthcare providers and patients. As awareness and demand for metabolic genetic testing continue to rise, the market is expected to witness further expansion in the coming years.
This report aims to provide a comprehensive presentation of the global market for Metabolic Genetic Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Metabolic Genetic Testing.
Report Scope
The Metabolic Genetic Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Metabolic Genetic Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Metabolic Genetic Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Centogene N.V
MedGenome
Blueprint Genetics Oy
Invitae Corporation
Quest Diagnostics
Orig3n
Bionano Genomics
Devyser
PerkinElmer Genomics
LabCorp
Centogene
PreventionGenetics
Segment by Type
DNA Sequencing
Targeted Gene Panels
Chromosomal Microarray Analysis (CMA)
Segment by Application
Hospitals
Specialty Clinics
Diagnostics Laboratories
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Metabolic Genetic Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Metabolic Genetic Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 DNA Sequencing
1.2.3 Targeted Gene Panels
1.2.4 Chromosomal Microarray Analysis (CMA)
1.3 Market by Application
1.3.1 Global Metabolic Genetic Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Diagnostics Laboratories
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Metabolic Genetic Testing Market Perspective (2019-2030)
2.2 Metabolic Genetic Testing Growth Trends by Region
2.2.1 Global Metabolic Genetic Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Metabolic Genetic Testing Historic Market Size by Region (2019-2024)
2.2.3 Metabolic Genetic Testing Forecasted Market Size by Region (2025-2030)
2.3 Metabolic Genetic Testing Market Dynamics
2.3.1 Metabolic Genetic Testing Industry Trends
2.3.2 Metabolic Genetic Testing Market Drivers
2.3.3 Metabolic Genetic Testing Market Challenges
2.3.4 Metabolic Genetic Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Metabolic Genetic Testing Players by Revenue
3.1.1 Global Top Metabolic Genetic Testing Players by Revenue (2019-2024)
3.1.2 Global Metabolic Genetic Testing Revenue Market Share by Players (2019-2024)
3.2 Global Metabolic Genetic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Metabolic Genetic Testing Revenue
3.4 Global Metabolic Genetic Testing Market Concentration Ratio
3.4.1 Global Metabolic Genetic Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Metabolic Genetic Testing Revenue in 2023
3.5 Metabolic Genetic Testing Key Players Head office and Area Served
3.6 Key Players Metabolic Genetic Testing Product Solution and Service
3.7 Date of Enter into Metabolic Genetic Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Metabolic Genetic Testing Breakdown Data by Type
4.1 Global Metabolic Genetic Testing Historic Market Size by Type (2019-2024)
4.2 Global Metabolic Genetic Testing Forecasted Market Size by Type (2025-2030)
5 Metabolic Genetic Testing Breakdown Data by Application
5.1 Global Metabolic Genetic Testing Historic Market Size by Application (2019-2024)
5.2 Global Metabolic Genetic Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Metabolic Genetic Testing Market Size (2019-2030)
6.2 North America Metabolic Genetic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Metabolic Genetic Testing Market Size by Country (2019-2024)
6.4 North America Metabolic Genetic Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Metabolic Genetic Testing Market Size (2019-2030)
7.2 Europe Metabolic Genetic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Metabolic Genetic Testing Market Size by Country (2019-2024)
7.4 Europe Metabolic Genetic Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Metabolic Genetic Testing Market Size (2019-2030)
8.2 Asia-Pacific Metabolic Genetic Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Metabolic Genetic Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Metabolic Genetic Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Metabolic Genetic Testing Market Size (2019-2030)
9.2 Latin America Metabolic Genetic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Metabolic Genetic Testing Market Size by Country (2019-2024)
9.4 Latin America Metabolic Genetic Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Metabolic Genetic Testing Market Size (2019-2030)
10.2 Middle East & Africa Metabolic Genetic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Metabolic Genetic Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Metabolic Genetic Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Centogene N.V
11.1.1 Centogene N.V Company Detail
11.1.2 Centogene N.V Business Overview
11.1.3 Centogene N.V Metabolic Genetic Testing Introduction
11.1.4 Centogene N.V Revenue in Metabolic Genetic Testing Business (2019-2024)
11.1.5 Centogene N.V Recent Development
11.2 MedGenome
11.2.1 MedGenome Company Detail
11.2.2 MedGenome Business Overview
11.2.3 MedGenome Metabolic Genetic Testing Introduction
11.2.4 MedGenome Revenue in Metabolic Genetic Testing Business (2019-2024)
11.2.5 MedGenome Recent Development
11.3 Blueprint Genetics Oy
11.3.1 Blueprint Genetics Oy Company Detail
11.3.2 Blueprint Genetics Oy Business Overview
11.3.3 Blueprint Genetics Oy Metabolic Genetic Testing Introduction
11.3.4 Blueprint Genetics Oy Revenue in Metabolic Genetic Testing Business (2019-2024)
11.3.5 Blueprint Genetics Oy Recent Development
11.4 Invitae Corporation
11.4.1 Invitae Corporation Company Detail
11.4.2 Invitae Corporation Business Overview
11.4.3 Invitae Corporation Metabolic Genetic Testing Introduction
11.4.4 Invitae Corporation Revenue in Metabolic Genetic Testing Business (2019-2024)
11.4.5 Invitae Corporation Recent Development
11.5 Quest Diagnostics
11.5.1 Quest Diagnostics Company Detail
11.5.2 Quest Diagnostics Business Overview
11.5.3 Quest Diagnostics Metabolic Genetic Testing Introduction
11.5.4 Quest Diagnostics Revenue in Metabolic Genetic Testing Business (2019-2024)
11.5.5 Quest Diagnostics Recent Development
11.6 Orig3n
11.6.1 Orig3n Company Detail
11.6.2 Orig3n Business Overview
11.6.3 Orig3n Metabolic Genetic Testing Introduction
11.6.4 Orig3n Revenue in Metabolic Genetic Testing Business (2019-2024)
11.6.5 Orig3n Recent Development
11.7 Bionano Genomics
11.7.1 Bionano Genomics Company Detail
11.7.2 Bionano Genomics Business Overview
11.7.3 Bionano Genomics Metabolic Genetic Testing Introduction
11.7.4 Bionano Genomics Revenue in Metabolic Genetic Testing Business (2019-2024)
11.7.5 Bionano Genomics Recent Development
11.8 Devyser
11.8.1 Devyser Company Detail
11.8.2 Devyser Business Overview
11.8.3 Devyser Metabolic Genetic Testing Introduction
11.8.4 Devyser Revenue in Metabolic Genetic Testing Business (2019-2024)
11.8.5 Devyser Recent Development
11.9 PerkinElmer Genomics
11.9.1 PerkinElmer Genomics Company Detail
11.9.2 PerkinElmer Genomics Business Overview
11.9.3 PerkinElmer Genomics Metabolic Genetic Testing Introduction
11.9.4 PerkinElmer Genomics Revenue in Metabolic Genetic Testing Business (2019-2024)
11.9.5 PerkinElmer Genomics Recent Development
11.10 LabCorp
11.10.1 LabCorp Company Detail
11.10.2 LabCorp Business Overview
11.10.3 LabCorp Metabolic Genetic Testing Introduction
11.10.4 LabCorp Revenue in Metabolic Genetic Testing Business (2019-2024)
11.10.5 LabCorp Recent Development
11.11 Centogene
11.11.1 Centogene Company Detail
11.11.2 Centogene Business Overview
11.11.3 Centogene Metabolic Genetic Testing Introduction
11.11.4 Centogene Revenue in Metabolic Genetic Testing Business (2019-2024)
11.11.5 Centogene Recent Development
11.12 PreventionGenetics
11.12.1 PreventionGenetics Company Detail
11.12.2 PreventionGenetics Business Overview
11.12.3 PreventionGenetics Metabolic Genetic Testing Introduction
11.12.4 PreventionGenetics Revenue in Metabolic Genetic Testing Business (2019-2024)
11.12.5 PreventionGenetics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Metabolic Genetic Testing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of DNA Sequencing
Table 3. Key Players of Targeted Gene Panels
Table 4. Key Players of Chromosomal Microarray Analysis (CMA)
Table 5. Global Metabolic Genetic Testing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Metabolic Genetic Testing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Metabolic Genetic Testing Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Metabolic Genetic Testing Market Share by Region (2019-2024)
Table 9. Global Metabolic Genetic Testing Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Metabolic Genetic Testing Market Share by Region (2025-2030)
Table 11. Metabolic Genetic Testing Market Trends
Table 12. Metabolic Genetic Testing Market Drivers
Table 13. Metabolic Genetic Testing Market Challenges
Table 14. Metabolic Genetic Testing Market Restraints
Table 15. Global Metabolic Genetic Testing Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Metabolic Genetic Testing Market Share by Players (2019-2024)
Table 17. Global Top Metabolic Genetic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metabolic Genetic Testing as of 2023)
Table 18. Ranking of Global Top Metabolic Genetic Testing Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Metabolic Genetic Testing Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Metabolic Genetic Testing Product Solution and Service
Table 22. Date of Enter into Metabolic Genetic Testing Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Metabolic Genetic Testing Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Metabolic Genetic Testing Revenue Market Share by Type (2019-2024)
Table 26. Global Metabolic Genetic Testing Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Metabolic Genetic Testing Revenue Market Share by Type (2025-2030)
Table 28. Global Metabolic Genetic Testing Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Metabolic Genetic Testing Revenue Market Share by Application (2019-2024)
Table 30. Global Metabolic Genetic Testing Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Metabolic Genetic Testing Revenue Market Share by Application (2025-2030)
Table 32. North America Metabolic Genetic Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Metabolic Genetic Testing Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Metabolic Genetic Testing Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Metabolic Genetic Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Metabolic Genetic Testing Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Metabolic Genetic Testing Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Metabolic Genetic Testing Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Metabolic Genetic Testing Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Metabolic Genetic Testing Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Metabolic Genetic Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Metabolic Genetic Testing Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Metabolic Genetic Testing Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Metabolic Genetic Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Metabolic Genetic Testing Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Metabolic Genetic Testing Market Size by Country (2025-2030) & (US$ Million)
Table 47. Centogene N.V Company Detail
Table 48. Centogene N.V Business Overview
Table 49. Centogene N.V Metabolic Genetic Testing Product
Table 50. Centogene N.V Revenue in Metabolic Genetic Testing Business (2019-2024) & (US$ Million)
Table 51. Centogene N.V Recent Development
Table 52. MedGenome Company Detail
Table 53. MedGenome Business Overview
Table 54. MedGenome Metabolic Genetic Testing Product
Table 55. MedGenome Revenue in Metabolic Genetic Testing Business (2019-2024) & (US$ Million)
Table 56. MedGenome Recent Development
Table 57. Blueprint Genetics Oy Company Detail
Table 58. Blueprint Genetics Oy Business Overview
Table 59. Blueprint Genetics Oy Metabolic Genetic Testing Product
Table 60. Blueprint Genetics Oy Revenue in Metabolic Genetic Testing Business (2019-2024) & (US$ Million)
Table 61. Blueprint Genetics Oy Recent Development
Table 62. Invitae Corporation Company Detail
Table 63. Invitae Corporation Business Overview
Table 64. Invitae Corporation Metabolic Genetic Testing Product
Table 65. Invitae Corporation Revenue in Metabolic Genetic Testing Business (2019-2024) & (US$ Million)
Table 66. Invitae Corporation Recent Development
Table 67. Quest Diagnostics Company Detail
Table 68. Quest Diagnostics Business Overview
Table 69. Quest Diagnostics Metabolic Genetic Testing Product
Table 70. Quest Diagnostics Revenue in Metabolic Genetic Testing Business (2019-2024) & (US$ Million)
Table 71. Quest Diagnostics Recent Development
Table 72. Orig3n Company Detail
Table 73. Orig3n Business Overview
Table 74. Orig3n Metabolic Genetic Testing Product
Table 75. Orig3n Revenue in Metabolic Genetic Testing Business (2019-2024) & (US$ Million)
Table 76. Orig3n Recent Development
Table 77. Bionano Genomics Company Detail
Table 78. Bionano Genomics Business Overview
Table 79. Bionano Genomics Metabolic Genetic Testing Product
Table 80. Bionano Genomics Revenue in Metabolic Genetic Testing Business (2019-2024) & (US$ Million)
Table 81. Bionano Genomics Recent Development
Table 82. Devyser Company Detail
Table 83. Devyser Business Overview
Table 84. Devyser Metabolic Genetic Testing Product
Table 85. Devyser Revenue in Metabolic Genetic Testing Business (2019-2024) & (US$ Million)
Table 86. Devyser Recent Development
Table 87. PerkinElmer Genomics Company Detail
Table 88. PerkinElmer Genomics Business Overview
Table 89. PerkinElmer Genomics Metabolic Genetic Testing Product
Table 90. PerkinElmer Genomics Revenue in Metabolic Genetic Testing Business (2019-2024) & (US$ Million)
Table 91. PerkinElmer Genomics Recent Development
Table 92. LabCorp Company Detail
Table 93. LabCorp Business Overview
Table 94. LabCorp Metabolic Genetic Testing Product
Table 95. LabCorp Revenue in Metabolic Genetic Testing Business (2019-2024) & (US$ Million)
Table 96. LabCorp Recent Development
Table 97. Centogene Company Detail
Table 98. Centogene Business Overview
Table 99. Centogene Metabolic Genetic Testing Product
Table 100. Centogene Revenue in Metabolic Genetic Testing Business (2019-2024) & (US$ Million)
Table 101. Centogene Recent Development
Table 102. PreventionGenetics Company Detail
Table 103. PreventionGenetics Business Overview
Table 104. PreventionGenetics Metabolic Genetic Testing Product
Table 105. PreventionGenetics Revenue in Metabolic Genetic Testing Business (2019-2024) & (US$ Million)
Table 106. PreventionGenetics Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Metabolic Genetic Testing Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Metabolic Genetic Testing Market Share by Type: 2023 VS 2030
Figure 3. DNA Sequencing Features
Figure 4. Targeted Gene Panels Features
Figure 5. Chromosomal Microarray Analysis (CMA) Features
Figure 6. Global Metabolic Genetic Testing Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Metabolic Genetic Testing Market Share by Application: 2023 VS 2030
Figure 8. Hospitals Case Studies
Figure 9. Specialty Clinics Case Studies
Figure 10. Diagnostics Laboratories Case Studies
Figure 11. Others Case Studies
Figure 12. Metabolic Genetic Testing Report Years Considered
Figure 13. Global Metabolic Genetic Testing Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Metabolic Genetic Testing Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Metabolic Genetic Testing Market Share by Region: 2023 VS 2030
Figure 16. Global Metabolic Genetic Testing Market Share by Players in 2023
Figure 17. Global Top Metabolic Genetic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metabolic Genetic Testing as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Metabolic Genetic Testing Revenue in 2023
Figure 19. North America Metabolic Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Metabolic Genetic Testing Market Share by Country (2019-2030)
Figure 21. United States Metabolic Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Metabolic Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Metabolic Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Metabolic Genetic Testing Market Share by Country (2019-2030)
Figure 25. Germany Metabolic Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Metabolic Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Metabolic Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Metabolic Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Metabolic Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Metabolic Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Metabolic Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Metabolic Genetic Testing Market Share by Region (2019-2030)
Figure 33. China Metabolic Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Metabolic Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Metabolic Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Metabolic Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Metabolic Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Metabolic Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Metabolic Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Metabolic Genetic Testing Market Share by Country (2019-2030)
Figure 41. Mexico Metabolic Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Metabolic Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Metabolic Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Metabolic Genetic Testing Market Share by Country (2019-2030)
Figure 45. Turkey Metabolic Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Metabolic Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Centogene N.V Revenue Growth Rate in Metabolic Genetic Testing Business (2019-2024)
Figure 48. MedGenome Revenue Growth Rate in Metabolic Genetic Testing Business (2019-2024)
Figure 49. Blueprint Genetics Oy Revenue Growth Rate in Metabolic Genetic Testing Business (2019-2024)
Figure 50. Invitae Corporation Revenue Growth Rate in Metabolic Genetic Testing Business (2019-2024)
Figure 51. Quest Diagnostics Revenue Growth Rate in Metabolic Genetic Testing Business (2019-2024)
Figure 52. Orig3n Revenue Growth Rate in Metabolic Genetic Testing Business (2019-2024)
Figure 53. Bionano Genomics Revenue Growth Rate in Metabolic Genetic Testing Business (2019-2024)
Figure 54. Devyser Revenue Growth Rate in Metabolic Genetic Testing Business (2019-2024)
Figure 55. PerkinElmer Genomics Revenue Growth Rate in Metabolic Genetic Testing Business (2019-2024)
Figure 56. LabCorp Revenue Growth Rate in Metabolic Genetic Testing Business (2019-2024)
Figure 57. Centogene Revenue Growth Rate in Metabolic Genetic Testing Business (2019-2024)
Figure 58. PreventionGenetics Revenue Growth Rate in Metabolic Genetic Testing Business (2019-2024)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
